11820

532637

MANGALAM

img img img img
No Data Available

MANGALAM DRUG & CHEM LTD Share Price Update

As of the latest trading session, MANGALAM DRUG & CHEM LTD is trading at ₹28.7, down by ₹-0.18 or -0.62% from its previous close. The stock has moved between ₹28.01 and ₹29.37 today. Over the past year, the stock has delivered a return of -64.17%. In the last month, it has returned 3.70%.

MANGALAM DRUG & CHEM LTD performance

Today’s low Today’s high
₹ 28.01 ₹ 29.37
₹ 28.83
52 week low 52 week high
₹ 22.80 ₹ 95.00
₹ 28.83
Open Price ₹ 28.89
Prev. Close ₹ 28.89
Volume (Shares) 17585.00
Total traded value ₹ 5.06
Upper Circuit ₹ 30.33
Lower Circuit ₹ 27.45
info

Investment Returns

Over 1 Month 3.70% Over 3 Months -0.85% Over 6 Months -1.97% Over 1 Year -64.17%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

MANGALAM DRUG & CHEM LTD fundamentals


  • Market cap (Cr) 45.60
  • P/E Ratio (TTM) -1.04
  • Beta 0.59
  • Book Value / share 65.27
  • Return on equity 4.76%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) -13.06
info icon alternate text
  • Market cap (Cr) 45.70
  • P/E Ratio (TTM) -1.04
  • Beta 0.55
  • Book Value / share 65.27
  • Return on equity 4.76%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) -13.06
info icon alternate text

MANGALAM DRUG & CHEM LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 67.29
Operating Expense 80.28
Net Profit -13.06
Net Profit Margin (%) -19.40
Earnings Per Share (EPS) -8.25
EBITDA -5.27
Effective Tax Rate (%) -1.16
Particulars DEC 2025 (Values in Cr)
Revenue 58.38
Operating Expense 68.36
Net Profit -9.78
Net Profit Margin (%) -16.75
Earnings Per Share (EPS) -6.18
EBITDA -1.35
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 49.26
Operating Expense 61.94
Net Profit -7.25
Net Profit Margin (%) -14.71
Earnings Per Share (EPS) -4.58
EBITDA -2.80
Effective Tax Rate (%) 41.39
Particulars JUN 2025 (Values in Cr)
Revenue 57.21
Operating Expense 70.27
Net Profit -13.73
Net Profit Margin (%) -23.99
Earnings Per Share (EPS) -8.67
EBITDA -4.51
Effective Tax Rate (%) -6.18
Particulars MAR 2025 (Values in Cr)
Revenue 72.78
Operating Expense 71.52
Net Profit 0.15
Net Profit Margin (%) 0.20
Earnings Per Share (EPS) 0.10
EBITDA 10.37
Effective Tax Rate (%) 91.32
Particulars MAR 2026 (Values in Cr)
Revenue 232.13
Operating Expense 280.89
Net Profit -43.81
Net Profit Margin (%) -18.87
Earnings Per Share (EPS) -27.68
EBITDA -13.94
Effective Tax Rate (%) 8.68
Particulars MAR 2025 (Values in Cr)
Revenue 317.58
Operating Expense 313.74
Net Profit 6.92
Net Profit Margin (%) 2.17
Earnings Per Share (EPS) 4.37
EBITDA 36.30
Effective Tax Rate (%) -38.67
Particulars MAR 2024 (Values in Cr)
Revenue 367.35
Operating Expense 379.75
Net Profit -9.05
Net Profit Margin (%) -2.46
Earnings Per Share (EPS) -5.72
EBITDA 17.49
Effective Tax Rate (%) 18.17
Particulars MAR 2023 (Values in Cr)
Revenue 370.20
Operating Expense 370.47
Net Profit 1.27
Net Profit Margin (%) 0.34
Earnings Per Share (EPS) 0.80
EBITDA 26.16
Effective Tax Rate (%) 42.53
Particulars MAR 2022 (Values in Cr)
Revenue 450.86
Operating Expense 423.42
Net Profit 19.66
Net Profit Margin (%) 4.36
Earnings Per Share (EPS) 12.42
EBITDA 49.14
Effective Tax Rate (%) 29.13
Particulars MAR 2025 (Values in Cr)
Book Value / Share 89.65
ROE % 4.84
ROCE % 8.07
Total Debt to Total Equity 0.73
EBITDA Margin 11.41
Particulars MAR 2024 (Values in Cr)
Book Value / Share 85.79
ROE % -6.68
ROCE % 1.16
Total Debt to Total Equity 0.79
EBITDA Margin 4.75
Particulars MAR 2025 (Values in Cr)
Book Value / Share 93.92
ROE % 4.76
ROCE % 7.94
Total Debt to Total Equity 0.70
EBITDA Margin 11.41
Particulars MAR 2024 (Values in Cr)
Book Value / Share 89.93
ROE % -6.15
ROCE % 1.15
Total Debt to Total Equity 0.66
EBITDA Margin 4.75
Particulars MAR 2023 (Values in Cr)
Book Value / Share 96.00
ROE % 0.84
ROCE % 6.25
Total Debt to Total Equity 0.58
EBITDA Margin 7.03
Particulars MAR 2022 (Values in Cr)
Book Value / Share 95.12
ROE % 13.98
ROCE % 17.57
Total Debt to Total Equity 0.56
EBITDA Margin 10.89
Particulars MAR 2021 (Values in Cr)
Book Value / Share 82.63
ROE % 23.83
ROCE % 27.41
Total Debt to Total Equity 0.52
EBITDA Margin 15.27
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.58
Total Assets 366.42
Total Liabilities 366.42
Total Equity 148.97
Share Outstanding 1
Price to Book Ratio 0.79
Return on Assets (%) 1.83
Return on Capital (%) 2.92
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.18
Total Assets 333.70
Total Liabilities 333.70
Total Equity 135.79
Share Outstanding 1
Price to Book Ratio 1.03
Return on Assets (%) -2.71
Return on Capital (%) -4.05
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.57
Total Assets 359.23
Total Liabilities 359.23
Total Equity 148.65
Share Outstanding 1
Price to Book Ratio 0.79
Return on Assets (%) 1.92
Return on Capital (%) 3.01
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.00
Total Assets 357.14
Total Liabilities 357.14
Total Equity 142.34
Share Outstanding 1
Price to Book Ratio 1.03
Return on Assets (%) -2.53
Return on Capital (%) -3.93
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.04
Total Assets 357.98
Total Liabilities 357.98
Total Equity 151.95
Share Outstanding 1
Price to Book Ratio 1.02
Return on Assets (%) 0.35
Return on Capital (%) 0.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.95
Total Assets 328.42
Total Liabilities 328.42
Total Equity 150.56
Share Outstanding 1
Price to Book Ratio 1.08
Return on Assets (%) 5.98
Return on Capital (%) 8.82
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.59
Total Assets 264.10
Total Liabilities 264.10
Total Equity 130.78
Share Outstanding 1
Price to Book Ratio 1.20
Return on Assets (%) 10.59
Return on Capital (%) 14.81
Particulars MAR 2025 (Values in Cr)
Net Income 4.78
Cash from Operations 42.67
Cash from Investing -19.47
Cash from Financing -21.71
Net change in Cash 1.40
Free Cash Flow 62.87
Particulars MAR 2024 (Values in Cr)
Net Income 3.97
Cash from Operations 4.00
Cash from Investing -11.82
Cash from Financing 5.22
Net change in Cash -2.68
Free Cash Flow 15.83
Particulars MAR 2025 (Values in Cr)
Net Income 4.98
Cash from Operations 42.84
Cash from Investing -19.47
Cash from Financing -21.71
Net change in Cash 1.57
Free Cash Flow 63.04
Particulars MAR 2024 (Values in Cr)
Net Income -11.05
Cash from Operations 12.35
Cash from Investing -17.90
Cash from Financing 5.69
Net change in Cash -0.03
Free Cash Flow 30.27
Particulars MAR 2023 (Values in Cr)
Net Income 2.21
Cash from Operations 38.05
Cash from Investing -22.17
Cash from Financing -16.82
Net change in Cash -0.91
Free Cash Flow 65.97
Particulars MAR 2022 (Values in Cr)
Net Income 27.73
Cash from Operations 34.51
Cash from Investing -27.32
Cash from Financing 2.97
Net change in Cash 1.36
Free Cash Flow 62.18
Particulars MAR 2021 (Values in Cr)
Net Income 39.51
Cash from Operations 36.81
Cash from Investing -31.28
Cash from Financing 2.69
Net change in Cash -1.03
Free Cash Flow 68.25
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.88 14.41 1.68 267.30 23.12 40.00
BLISS GVS PHARMA LTD. 396.35 32.07 3.51 4192.95 118.35 399.00
CIPLA LTD 1418.20 28.08 3.32 114562.27 1165.55 1672.20
FERMENTA BIOTECH LIMITED 293.20 12.93 2.12 862.92 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.88 24.39 4.49 267.30 23.12 40.00
AMRUTAJAN HEALTH LTD 559.20 25.06 4.36 1616.68 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8655.30 104.02 27.08 21638.25 7630.00 10653.05
BLISS GVS PHARMA LTD. 396.35 42.62 3.62 4192.95 118.35 399.00

MANGALAM DRUG & CHEM LTD shareholding pattern

Holding
64.02%
35.65%
0.32%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

MANGALAM DRUG & CHEM LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
28.83 -0.20 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 29.30
  • 26 Days 29.80
  • 10 Days 29.60
  • 50 Days 30.40
  • 12 Days 29.60
  • 100 Days 34.20
  • 20 Days 29.70
  • 200 Days 45.50
29.13 PIVOT
First Support 28.37 First Resistance 29.66 Second Support 27.84 Second Resistance 30.42 Third Support 27.08 Third Resistance 30.95
RSI 42.56 ADX 21.22 MACD -0.15 Williams % R -76.44 Commodity Channel Index (CCI) -155.44
Date [-] Week 0.0 Same Day 0.0 Month 0.0
1 Year 0.59 3 Year 0.81
Over 1 Month
3.70% down
Over 1 Year
-64.17% down
Over 3 Months
-0.85% down
Over 3 Years
-35.42% down
Over 6 Months
-1.97% down
Over 5 Years
-26.44% down

MANGALAM DRUG & CHEM LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
21 Dec 2017 0.5 Interim 22 Dec 2017 Equity shares
30 Aug 2005 0.0 Final 01 Sep 2005 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
21 Dec 2017 0.5 Interim 22 Dec 2017 Equity shares
30 Aug 2005 0.0 Final 01 Sep 2005 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Mangalam Drugs and Organics Ltd?

Answer Field

Mangalam Drugs and Organics Ltd share price is for NSE ₹ 28.70 & for BSE ₹ 28.90 as on May 27 2026 03:26 PM.

What is the Market Cap of Mangalam Drugs and Organics Ltd Share?

Answer Field

The market cap of Mangalam Drugs and Organics Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on May 27 2026 03:26 PM.

What is the 52 Week High and Low of Mangalam Drugs and Organics Ltd?

Answer Field

The 52 Week High and Low of Mangalam Drugs and Organics Ltd for NSE is ₹ 95.00 and ₹ 22.80 and for BSE is ₹ 94.80 and ₹ 22.70.

What is 1 year return for Mangalam Drugs and Organics Ltd?

Answer Field

The 1 year returns on the stock has been -64.17%.

What is the P/E Ratio of Mangalam Drugs and Organics Ltd Share?

Answer Field

As on May 27 2026 03:26 PM the price-to-earnings (PE) ratio for Mangalam Drugs and Organics Ltd share is -1.04.

What is the PB ratio of Mangalam Drugs and Organics Ltd Share?

Answer Field

As on May 27 2026 03:26 PM, the price-to-book (PB) ratio for Mangalam Drugs and Organics Ltd share is 65.27.

How to Buy Mangalam Drugs and Organics Ltd Share?

Answer Field

You can trade in Mangalam Drugs and Organics Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Mangalam Drugs and Organics Ltd Share on Bajaj Broking App?

Answer Field

To buy Mangalam Drugs and Organics Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Mangalam Drugs and Organics Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|